Personalized shield: daily pill aims to block deadly infections for new kidney recipients
Prevention
Not yet recruiting
This study aims to prevent dangerous bloodstream infections in people who have recently received a kidney transplant. It will test if a daily antibiotic pill, given for five months to patients identified as high-risk, is better than a placebo at stopping these infections. The goa…
Phase: PHASE2 • Sponsor: Susanne Dam Nielsen, MD, DMSc • Aim: Prevention
Last updated Mar 30, 2026 14:33 UTC